check_circleStudy Completed

Hypertension

The Real-Life Efficacy and Safety of Telmisartan in Patients with Arterial Hypertension

Trial purpose

The main purpose of this study is to asses the efficacy and safety of telmisartan, with the special attention on the influence of telmisartan on selected metabolic parameters of patients.

Key Participants Requirements

Sex

Both

Age

18 Years
  • - Age over 18
    - Untreated or ineffectively treated arterial hypertension
  • - Cholestatic disorders and severe hepatic failure
    - Allergy to telmisartan
    - Pregnancy and lactation period

Trial summary

Enrollment Goal
5448
Trial Dates
September 2006 - January 2008
Phase
N/A
Could I Receive a placebo
No
Products
Kinzal/Pritor (Telmisartan, BAY68-9291)
Accepts Healthy Volunteer
No

Where to participate

StatusInstitutionLocation
Completed
Many locations, Croatia
Completed
Many locations, Slovenia
Completed
Many locations, Poland
Completed
Many locations, Slovakia

Primary Outcome

  • Efficacy and safety of the treatment with telmisartan reported by the physician
    date_rangeTime Frame:
    At the both of planned control visits. (Approx. interval between visits 3 months)
    enhanced_encryption
    Safety Issue:
    Yes

Secondary Outcome

  • Changes in metabolic parameters in telmisartan treated patients
    date_rangeTime Frame:
    At the both of planned control visits. (Approx. interval between visits 3 months)
    enhanced_encryption
    Safety Issue:
    No

Trial design

A Non-Interventional, Post-Marketing Surveillance Phase IV Study to Asses the Efficacy and Safety of Telmisartan, With the Special Attention on the Influence of Telmisartan on Selected Metabolic Parameters of Patients
Trial Type
Observational
Intervention Type
Drug
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A